Jesper B Andersen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Venues

Hepatology (Baltimore, Md.)

Nature communications

Nature reviews. Gastroenterology & hepatology

Molecular cancer therapeutics

Københavns Universitet

Aarhus Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Københavns Universitet Jan 01 2014

Denmark

Associate Professor and Group leader :: Health and Medical Sciences, Biotech Research and Innovation Centre (BRIC)

National Cancer Institute Feb 20 2007 - Sep 01 2014

United States

Postdoc research fellow :: CCR

University of Maryland Baltimore Jun 13 2003 - Feb 01 2007

United States

Research Fellow :: Microbiology and Immunology, Greenebaum Cancer center

Aarhus Universitet Jan 13 2003 - Jun 01 2003

Denmark

Reearch Assistent :: Molecular and Structural Biology

Education History

Aarhus Universitet Jun 13 2003 - Dec 11 2006

Denmark

PHD :: Molecular and Structural Biology

Aarhus Universitet Aug 01 1996 - Jan 13 2003

Denmark

MSC :: Molecular and Structural Biology

Publications

Friederike L Keggenhoff, Darko Castven, Diana Becker, Stojan Stojkovic, Jovana Castven, Carolin Zimpel, Beate K Straub, Tiemo Gerber, Harald Langer, Patricia Hähnel, Thomas Kindler, Jörg Fahrer, Colm J O'Rourke, Ursula Ehmer, Anna Saborowski, Lichun Ma, Xin Wei Wang, Timo Gaiser, Matthias S Matter, Christian Sina, Stefanie Derer, Ju-Seog Lee, Stephanie Roessler, Bernd Kaina, Jesper B Andersen, Peter R Galle, Jens-Uwe Marquardt
PARP-1 selectively impairs KRAS -driven phenotypic and molecular features in intrahepatic cholangiocarcinoma. Gut (2024)
Pedro M Rodrigues, Marta B Afonso, André L Simão, Tawhidul Islam, Maria M Gaspar, Colm J O'Rourke, Monika Lewinska, Jesper B Andersen, Enara Arretxe, Cristina Alonso, Álvaro Santos-Laso, Laura Izquierdo-Sanchez, Raúl Jimenez-Agüero, Emma Eizaguirre, Luis Bujanda, Maria J Pareja, Carina Prip-Buus, Jesus Maria Banales, Cecília Maria Pereira Rodrigues, Rui E Castro
miR-21-5p promotes NASH-related hepatocarcinogenesis. Liver international : official journal of the International Association for the Study of the Liver (2023)
Colm J O'Rourke, Massimiliano Salati, Colin Rae, Carpino Guido, Holly Leslie, Antonio Pea, Maria G Prete, Luca R Bonetti, Francesco Amato, Robert Montal, Rosie Upstill-Goddard, Colin Nixon, Paula Sanchon-Sanchez, Paolo Kunderfranco, Daniela Sia, Eugenio Gaudio, Diletta Overi, Stefano Cascinu, Dan Hogdall, Sian Pugh, Enric Domingo, John N Primrose, John Bridgewater, Andrea Spallanzani, Fabio Gelsomino, Josep M Llovet, Diego F Calvisi, Luke Boulter, Francesco Caputo, Ana Lleo, Nigel B Jamieson, Gabriele Luppi, Massimo Dominici, Jesper B Andersen, Chiara Braconi
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy. Gut (2023)
Diego F Calvisi, Luke Boulter, Javier Vaquero, Anna Saborowski, Luca Fabris, Pedro M Rodrigues, Cédric Coulouarn, Rui E Castro, Oreste Segatto, Chiara Raggi, Luc J W van der Laan, Carpino Guido, Benjamin Goeppert, Stephanie Roessler, Timothy James Kendall, Matthias Evert, Ester Gonzalez-Sanchez, Juan W Valle, Arndt Vogel, John A Bridgewater, Mitesh J Borad, Gregory J Gores, Lewis Rowland Roberts, Jose J G Marin, Jesper B Andersen, Domenico Alvaro, Alejandro Forner, Jesus Maria Banales, Vincenzo Cardinale, Rocío I R Macías, Silvestre Vincent, Xin Chen, Chiara Braconi, Monique M A Verstegen, Laura Fouassier, null null
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance. Nature reviews. Gastroenterology & hepatology (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics 22 (3) (2023)
Chirag Nepal, Jesper B Andersen
Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes. Nature communications 14 (1) (2023)
Monika Lewinska, Martin Lund Kårhus, Anne-Marie Gade Ellegaard, Manuel Romero, Rocío I R Macías, Jesper B Andersen, Filip K Krag Knop
Serum lipidome unravels a diagnostic potential in bile acid diarrhoea. Gut (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics 22 (3) (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics 22 (3) (2023)
Chirag Nepal, Jesper B Andersen
Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes. Nature communications 14 (1) (2023)
Diego F Calvisi, Luke Boulter, Javier Vaquero, Anna Saborowski, Luca Fabris, Pedro M Rodrigues, Cédric Coulouarn, Rui E Castro, Oreste Segatto, Chiara Raggi, Luc J W van der Laan, Carpino Guido, Benjamin Goeppert, Stephanie Roessler, Timothy James Kendall, Matthias Evert, Ester Gonzalez-Sanchez, Juan W Valle, Arndt Vogel, John A Bridgewater, Mitesh J Borad, Gregory J Gores, Lewis Rowland Roberts, Jose J G Marin, Jesper B Andersen, Domenico Alvaro, Alejandro Forner, Jesus Maria Banales, Vincenzo Cardinale, Rocío I R Macías, Silvestre Vincent, Xin Chen, Chiara Braconi, Monique M A Verstegen, Laura Fouassier, null null
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance. Nature reviews. Gastroenterology & hepatology (2023)
Chirag Nepal, Jesper B Andersen
Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes. Nature communications 14 (1) (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics (2023)
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus Maria Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular cancer therapeutics 22 (3) (2023)
Chirag Nepal, Jesper B Andersen
Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes. Nature communications 14 (1) (2023)
Mikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, Pedro M Rodrigues, Ainhoa Lapitz, Beatriz Gómez-Santos, Paula Olaizola, Sabina Di Matteo, Igor Aurrekoetxea, Ibone Labiano, Ane Nieva-Zuluaga, Asier Benito-Vicente, María J Perugorria, Maider Apodaka-Biguri, Nuno A Paiva, Diego Sáenz de Urturi, Xabier Buqué, Igotz Delgado, César Martín, Mikel Azkargorta, Felix Elortza, Diego F Calvisi, Jesper B Andersen, Domenico Alvaro, Vincenzo Cardinale, Luis Bujanda, Jesús M Banales, Patricia Aspichueta
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids. Hepatology (Baltimore, Md.) 76 (6) (2022)
Ekaterina Zhuravleva, Colm J O'Rourke, Jesper B Andersen
Mutational signatures and processes in hepatobiliary cancers. Nature reviews. Gastroenterology & hepatology 19 (6) (2022)
Cristina Quintavalle, Nathalie Meyer-Schaller, Stephanie Roessler, Diego Calabrese, Romina Marone, Tobias Riedl, Silvia Picco-Rey, Orestis A Panagiotou, Sarp Uzun, Salvatore Piscuoglio, Tuyana Boldanova, Chaoran B Bian, David Semela, Wolfram Jochum, Gieri Cathomas, Kirsten D Mertz, Joachim Diebold, Luca Mazzucchelli, Viktor H Koelzer, Achim Weber, Thomas Decaens, Luigi M Terracciano, Mathias Heikenwalder, Yujin Hoshida, Jesper B Andersen, Snorri S Thorgeirsson, Matthias S Matter
miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed Liver. Hepatology communications 6 (6) (2022)
Jesper B Andersen
Stromal yin-yang of myofibroblasts and endothelial cells in the progression of intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md.) 76 (5) (2022)
Francisco González-Romero, Daniela Mestre, Igor Aurrekoetxea, Colm J O'Rourke, Jesper B Andersen, Ashwin Woodhoo, Miguel Tamayo-Caro, Marta Varela-Rey, Marta Palomo-Irigoyen, Beatriz Gómez-Santos, Diego Sáenz de Urturi, Maitane Núñez-García, Juan Luis García-Rodríguez, Larraitz Fernández-Ares, Xabier Buqué, Ainhoa Iglesias-Ara, Irantzu Bernales, Virginia Gutierrez De Juan, Teresa Cardoso Delgado, Naroa Goikoetxea-Usandizaga, Richard Lee, Sanjay Bhanot, Igotz Delgado, Maria J Perugorria, Gaizka Errazti, Lorena Mosteiro, Sonia Gaztambide, Idoia Martinez de la Piscina, Paula Iruzubieta, Javier Crespo, Jesus M Banales, María Luz Martínez-Chantar, Luis Castaño, Ana M Zubiaga, Patricia Aspichueta
E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment. Cancer research 81 (11) (2021)
Christine L Zimmer, Iva Filipovic, Martin Cornillet, Colm J O'Rourke, Lena Berglin, Hannes Jansson, Dan Sun, Otto Strauss, Laura Hertwig, Helene Johansson, Erik von Seth, Ernesto Sparrelid, Joana Dias, Hans Glaumann, Espen Melum, Ewa C S Ellis, Johan K Sandberg, Jesper B Andersen, Annika Bergquist, Niklas K Björkström
MAIT cell tumor infiltration predicts long-term survival in cholangiocarcinoma. Hepatology (Baltimore, Md.) (2021)
Alessandra Gentilini, Giulia Lori, Alessandra Caligiuri, Chiara Raggi, Giovanni Di Maira, Mirella Pastore, Benedetta Piombanti, Tiziano Lottini, Annarosa Arcangeli, Stefania Madiai, Nadia Navari, Jesus M Banales, Sabina Di Matteo, Domenico Alvaro, Lea Duwe, Jesper B Andersen, Alessandro Tubita, Ignazia Tusa, Luca Di Tommaso, Claudia Campani, Elisabetta Rovida, Fabio Marra
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells. Hepatology (Baltimore, Md.) 74 (4) (2021)
Margherita Correnti, Andrea Cappon, Mirella Pastore, Benedetta Piombanti, Giulia Lori, Douglas V P N Oliveira, Patricia Munoz-Garrido, Monika Lewinska, Jesper B Andersen, Cédric Coulouarn, Laurent Sulpice, Caterina Peraldo Neia, Giuliana Cavalloni, Santina Quarta, Alessandra Biasiolo, Matteo Fassan, Matteo Ramazzotti, Matteo Parri, Stefania Recalcati, Luca di Tommaso, Claudia Campani, Invernizzi Pietro, Guido Torzilli, Fabio Marra, Patrizia Pontisso, Chiara Raggi
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver (2021)
Chirag Nepal, Yavor Hadzhiev, Piotr J Balwierz, Estefanía Tarifeño-Saldivia, Ryan Cardenas, Joseph W Wragg, Ana-Maria Suzuki, Piero Carnici, Bernard Peers, Boris Lenhard, Jesper B Andersen, Ferenc Müller
Dual-initiation promoters with intertwined canonical and TCT/TOP transcription start sites diversify transcript processing. Nature communications 11 (1) (2020)
Colm J O'Rourke, Patricia Munoz-Garrido, Jesper B Andersen
Molecular Targets in Cholangiocarcinoma. Hepatology (Baltimore, Md.) (2020)
Aitor Esparza-Baquer, Ibone Labiano, Omar Sharif, Aloña Agirre-Lizaso, Fiona Oakley, Pedro M Rodrigues, Ekaterina Zhuravleva, Colm J O'Rourke, Elizabeth Hijona, Raul Jimenez-Agüero, Ioana Riaño, Ana Landa, Adelaida La Casta, Marco Y W Zaki, Patricia Munoz-Garrido, Mikel Azkargorta, Felix Elortza, Andrea Vogel, Gernot Schabbauer, Patricia Aspichueta, Jesper B Andersen, Sylvia Knapp, Derek A Mann, Luis Bujanda, Jesus Maria Banales, Maria Jesus Perugorria
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms. Gut 70 (7) (2020)
Jesus Maria Banales, Jose J G Marin, Angela Lamarca, Pedro M Rodrigues, Shahid A Khan, Lewis Rowland Roberts, Vincenzo Cardinale, Carpino Guido, Jesper B Andersen, Chiara Braconi, Diego F Calvisi, Maria J Perugorria, Luca Fabris, Luke Boulter, Rocío I R Macías, Eugenio Gaudio, Domenico Alvaro, Sergio A Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Invernizzi Pietro, Joachim C Mertens, Anja Moncsek, Sumera Rizvi, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John A Bridgewater, Juan W Valle, Gregory J Gores
Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature reviews. Gastroenterology & hepatology 17 (9) (2020)
Jesus M Banales, Vincenzo Cardinale, Rocio I R Macias, Jesper B Andersen, Chiara Braconi, Carpino Guido, Domenico Alvaro, Diego F Calvisi
Cholangiocarcinoma: State-of-the-art knowledge and challenges. Liver international : official journal of the International Association for the Study of the Liver (2020)
Giovanni Di Maira, Alessandra Gentilini, Mirella Pastore, Alessandra Caligiuri, Benedetta Piombanti, Chiara Raggi, Elisabetta Rovida, Monika Lewinska, Jesper B Andersen, Christian Borgo, Mauro Salvi, Daniele Ottaviani, Maria Ruzzene, Fabio Marra
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells. Oncogenesis 8 (11) (2019)
Chiara Braconi, Stephanie Roessler, Beata Kruk, Frank Lammert, Marcin Krawczyk, Jesper B Andersen
Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine? Liver international : official journal of the International Association for the Study of the Liver (2019)
Ruba Al-Abdulla, Elisa Lozano, Rocio I R Macias, Maria J Monte, Oscar Briz, Colm J O'Rourke, Maria A Serrano, Jesus M Banales, Matias A Avila, Maria L Martinez-Chantar, Andreas Geier, Jesper B Andersen, Jose J G Marin
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib. British journal of pharmacology 176 (6) (2019)
Colm J O'Rourke, Matthias S Matter, Chirag Nepal, Rui Caetano-Oliveira, Phuongnga T Ton, Valentina M Factor, Jesper B Andersen
Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven Cholangiocarcinoma. Hepatology (Baltimore, Md.) 71 (1) (2019)
M Ilcim Thestrup, Sara Caviglia, Jordi Cayuso, Ronja L S Heyne, Racha Ahmad, Wolfgang Hofmeister, Letizia Satriano, David G Wilkinson, Jesper B Andersen, Elke Annette Ober
A morphogenetic EphB/EphrinB code controls hepatopancreatic duct formation. Nature communications 10 (1) (2019)
Elisa Lozano, Rocío I R Macías, Maria J Monte, Maitane Asensio, Sofia Del Carmen, Laura Sanchez-Vicente, Marta Alonso-Peña, Ruba Al-Abdulla, Patricia Munoz-Garrido, Letizia Satriano, Colm J O'Rourke, Jesus M Banales, Matias A Avila, Maria L Martinez-Chantar, Jesper B Andersen, Oscar Briz, Jose J G Marin
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy. Hepatology (Baltimore, Md.) 70 (4) (2019)
Letizia Satriano, Monika Lewinska, Pedro M Rodrigues, Jesus Maria Banales, Jesper B Andersen
Metabolic rearrangements in primary liver cancers: cause and consequences. Nature reviews. Gastroenterology & hepatology 16 (12) (2019)
Chirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, Andrzej Taranta, Steven Shema, Prson Gautam, Julien Calderaro, Andrew Barbour, Chiara Raggi, Krister Wennerberg, Xin W Wang, Anja Lautem, Lewis Rowland Roberts, Jesper B Andersen
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md.) 68 (3) (2018)

Jesper B Andersen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jesper B Andersen